POM-V Prescription Required

Planate 87.5 micrograms/ml Solution for Injection

Active ingredient: Cloprostenol

Form

Injection

Species

Pigs

Manufacturer

Intervet International B.V.

VMD MA No.

06376/5063

What it's used for

- - -

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Cloprostenol

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Planate 87.5 micrograms/ml Solution for Injection — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

-
-
-

Administer a single dose of 2 ml per animal (equivalent to 175 micrograms of
cloprostenol).
The stopper may be safely punctured up to 10 times. When treating groups of
animals in one run, use a draw-off needle that has been placed in the vial stopper
to avoid excess broaching of the stopper. The draw-off needle should be removed
after treatment.

Do not use in pregnant animals in which the induction of parturition is not intended.
Do not administer to induce parturition in animals with suspected dystocia due to
mechanical obstruction or abnormal position, presentation and/or posture of the
foetus.
Do not use in cases of bronchospasm or gastrointestinal dysmotility.
Do not use in cases of hypersensitivity to the active substance or to any of the
excipients.

Pigs (sows and gilts):
Rare
(1 to 10 animals / 10,000 animals
treated)
Injection site infection
; Very rare
(<1 animal / 10,000 animals
treated, including isolated reports):
Restlessness
,
Frequent urination
;
Diarrhoea
Retained placenta
, Metritis
, Dystocia
,
Stillbirth
1
May occur if anaerobic bacteria enter the injection site and may become
generalized. Careful aseptic techniques should be employed to decrease the
possibility of these infections.
May be observed within 15 minutes post-injection and usually disappears after
one hour.
May be caused by induction of parturition with any exogenous compound.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian,
to either the marketing authorisation holder or the national competent authority via
the national reporting system. See the package leaflet for respective contact
details.

The response of sows and gilts to induction of parturition may be influenced by the
physiological state and the time of treatment. The vast majority of the animals,
95%, will commence farrowing within 36 hours of treatment. The majority of
animals can be expected to respond within the period of 24+/- 5 hours following
the injection, except in those cases where spontaneous parturition is imminent.

Special precautions for safe use in the target species:
To reduce the risk of anaerobic infections arising from vasoconstriction at the
injection site, injections into contaminated (wet or dirty) skin areas should be
avoided. Thoroughly clean and disinfect injection sites prior to administration.
Injection into adipose tissue may lead to incomplete absorption of the veterinary
medicinal product.
Premature induction of farrowing will reduce the piglet`s birth weight and increase
the number of stillborn piglets and non-viable and immature born piglets. It is
essential that the mean length of gestation is calculated on each farm from past
records and not to anticipate the term of gestation by more than two days.
Do not administer intravenously.
Special precautions to be taken by the person administering the veterinary
medicinal product to animals:
Prostaglandins of the F2α type, such as cloprostenol, may be absorbed through
the skin and may cause bronchospasm or miscarriage.
Care should be taken when handling the veterinary medicinal product to avoid
self-injection or skin contact.
Pregnant women, women of child-bearing age, asthmatics and persons with other
respiratory tract diseases should avoid contact when handling this veterinary
medicinal product.
Personal protective equipment consisting of impervious gloves should be worn
when handling the veterinary medicinal product.
Accidental spillage on the skin should be washed immediately with soap and
water. In case of accidental self-injection or spillage onto the skin seek medical
advice immediately, particularly as shortness of breath may occur, and show the
package label or leaflet to the physician.
This veterinary medicinal product may cause hypersensitivity reactions. People
with known hypersensitivity to benzyl alcohol should avoid contact with the
veterinary medicinal product.
Wash hands after use.
Special precautions for the protection of the environment:
Not applicable.

The concomitant use of oxytocin and cloprostenol increases the effects on the
uterus.
Do not administer with non-steroidal anti-inflammatory drugs (NSAIDs) since they
inhibit endogenous prostaglandin synthesis.
In animals to which a progestogen is being administered, a decrease in the
response of cloprostenol can be expected.

Keep the vial in the outer carton in order to protect from light.
Do not freeze.

Meat and offal: 1 day.
4.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.